EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

miR‐138‐5p Inhibits Aortic Valve Interstitial by Targeting SLC39A14 and Activating Nrf2 Signaling

Fei Yan iD, Ying Zhao, Yuanyuan Wu, Dubiao Xian, Lei Shi, Yunheng Liang, Ning Wang, Ruiling He, Hongwang Cui, Zhihao Xie

Journal of Biochemical and Molecular Toxicology · 2026

DOI: 10.1002/jbt.71034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2026. Verfasst von Fei Yan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China. Hauptthemen laut MEDLINE: MicroRNAs, Aortic Valve, NF-E2-Related Factor 2, Signal Transduction. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study explored the role of miR‐138‐5p in calcific aortic valve disease (CAVD), focusing on its regulation of osteogenic differentiation in human aortic valve interstitial cells (hAVICs) and underlying mechanisms. Aortic valve tissues from CAVD patients and controls were analyzed for miR‐138‐5p expression using qRT‐PCR. hAVICs were cultured in osteogenic medium (OM) and transfected with miR‐138‐5p mimics or inhibitors. Calcification was evaluated via ALP and Alizarin Red staining. Western blot assessed osteogenic markers (RUNX2, ALP, OPN, BMP‐2). Dual‐luciferase assays confirmed miR‐138‐5p targeting of SLC39A14. The role of SLC39A14 and the Nrf2 pathway was examined through overexpression experiments and Western blot for Nrf2, HO‐1, and NQO1. ML385 was used to inhibit Nrf2. miR‐138‐5p was significantly downregulated in CAVD tissues and OM‐induced hAVICs. Overexpression of miR‐138‐5p inhibited calcification, reducing ALP activity, nodule formation, and osteogenic marker expression. Inhibition of miR‐138‐5p promoted calcification. SLC39A14, upregulated in CAVD, was validated as a direct target of miR‐138‐5p . Its overexpression promoted calcification, which was reversed by co‐transfection with miR‐138‐5p . Mechanistically, miR‐138‐5p was associated with activation of the Nrf2 pathway, as evidenced by increased Nrf2 nuclear translocation and HO‐1/NQO1 expression, whereas SLC39A14 overexpression showed the opposite effect. Nrf2 inhibition with ML385 diminished the anti‐calcific effect of miR‐138‐5p . miR‐138‐5p inhibits hAVIC calcification, at least in part through regulation of SLC39A14 and the Nrf2 pathway, highlighting a potentially important regulatory mechanism in CAVD and a candidate therapeutic target for valve calcification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsAortic ValveNF-E2-Related Factor 2Signal TransductionAortic Valve StenosisCalcinosisCation Transport ProteinsHumansOsteogenesisMaleFemaleCells, Cultured

Stichwörter der Autor:innen

MicroRNA‐138‐5p (miR‐138‐5p)Nrf2 pathwaySLC39A14calcific aortic valve disease (CAVD)osteogenic differentiation

Substanzen

MicroRNAsNF-E2-Related Factor 2NFE2L2 protein, humanMIRN138 microRNA, humanCation Transport Proteins

Autor:innen und Institutionen

  • Department of Cardiac Surgery, First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China.
  • Key Laboratory of Emergency and Trauma of Ministry of Education, Haikou, Hainan, China.
  • Engineering Research Center for Hainan Biological Sample Resources of Major Diseases, Haikou, Hainan, China.

ORCID-Profile: Fei Yan

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yan, F., Zhao, Y., Wu, Y., Xian, D., Shi, L., Liang, Y., Wang, N., He, R., Cui, H., & Xie, Z. (2026). miR‐138‐5p Inhibits Aortic Valve Interstitial by Targeting SLC39A14 and Activating Nrf2 Signaling. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.71034

Vancouver

Yan F, Zhao Y, Wu Y, Xian D, Shi L, Liang Y, et al. miR‐138‐5p Inhibits Aortic Valve Interstitial by Targeting SLC39A14 and Activating Nrf2 Signaling. Journal of Biochemical and Molecular Toxicology. 2026. doi:10.1002/jbt.71034

BibTeX
@article{Yan2026,
  author = {Yan, Fei and Zhao, Ying and Wu, Yuanyuan and Xian, Dubiao and Shi, Lei and Liang, Yunheng and Wang, Ning and He, Ruiling and Cui, Hongwang and Xie, Zhihao},
  title = {miR‐138‐5p Inhibits Aortic Valve Interstitial by Targeting SLC39A14 and Activating Nrf2 Signaling},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2026},
  doi = {10.1002/jbt.71034}
}
Kostenlos starten →